Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | June Roundup
Liquid Biopsy (LBx) in June was spearheaded by novel company partnerships and product launches as well as clinical trial launches and validation study result updates.
July 11, 2022
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | June Roundup
Liquid Biopsy (LBx) in June was spearheaded by novel company partnerships and product launches as well as clinical trial launches and validation study result updates.
July 11, 2022
Liquid Biopsy
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | June Roundup
June was a busy month with funding rounds, study results, and manufacturing partnerships bringing a range of next gen therapeutics closer to the clinic. Happy reading!
July 1, 2022
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | June Roundup
June was a busy month with funding rounds, study results, and manufacturing partnerships bringing a range of next gen therapeutics closer to the clinic. Happy reading!
July 1, 2022
Next-Generation Therapeutics
Blog Article
Pharma & Biotech
Multiomics takes centerstage at PMWC 2022
Our life science expert highlights a key insight from this year's Precision World Medicine Conference. From digital biomarkers to liquid biopsy, read how multiomics is becoming a central part of precision medicine
July 1, 2022
Blog Article
Pharma & Biotech
Multiomics takes centerstage at PMWC 2022
Our life science expert highlights a key insight from this year's Precision World Medicine Conference. From digital biomarkers to liquid biopsy, read how multiomics is becoming a central part of precision medicine
July 1, 2022
multiomics
Biomarkers
.png)
Newsletter Update
Pharma & Biotech
Digital Health | Q2 Update
We’ve rounded up the big headlines for you, from an Office of Inspector General data brief to exciting regulatory approvals, product launches, partnerships, and acquisitions in the digital health space.
July 1, 2022
Newsletter Update
Pharma & Biotech
Digital Health | Q2 Update
We’ve rounded up the big headlines for you, from an Office of Inspector General data brief to exciting regulatory approvals, product launches, partnerships, and acquisitions in the digital health space.
July 1, 2022
Medical Devices
Health Technology Market
Digital Health
DeciBio Q&A
Pharma & Biotech
The Next Frontier of Sensitivity: DeciBio’s Q&A with Stephane Mouradian of Personalis
DeciBio interviews Stephane Mouradian, Senior Vice President of BD & Marketing at Personalis, about the focus of the company moving forward and their highly sensitive NeXT Personal™ assay.
June 24, 2022
DeciBio Q&A
Pharma & Biotech
The Next Frontier of Sensitivity: DeciBio’s Q&A with Stephane Mouradian of Personalis
DeciBio interviews Stephane Mouradian, Senior Vice President of BD & Marketing at Personalis, about the focus of the company moving forward and their highly sensitive NeXT Personal™ assay.
June 24, 2022
MRD Testing
In The Press
Pharma Manufacturing - mRNA boom: A double-edged sword
Did short-term solutions for COVID-19 stifle long-term mRNA success?
June 23, 2022
In The Press
Pharma Manufacturing - mRNA boom: A double-edged sword
Did short-term solutions for COVID-19 stifle long-term mRNA success?
June 23, 2022
No items found.
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved